Ownership history in Pendal Group Ltd · 2 quarters on record
This page tracks every 13F SEC filing in which Pendal Group Ltd reported a position in GLOBAL BLOOD THERAPEUTICS IN (GBT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2022 Q3 | REDUCED | 3,420 | -2,273 | -39.9% | 0.00% | $233K | — |
| 2020 Q2 | INITIATED | 5,693 | — | — | 0.00% | $359K | — |